{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:28Z","timestamp":1792097308899,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cpet.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:06Z","timestamp":1792096926000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["18F-Fluorodeoxyglucose PET in Rheumatologic and Autoimmune Disorders"],"prefix":"10.1016","author":[{"given":"Aman","family":"Tilak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Toshniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cpet.2026.09.002_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","article-title":"Xist ribonucleoproteins promote female sex-biased autoimmunity","volume":"187","author":"Dou","year":"2024","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cpet.2026.09.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103210","article-title":"Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases","volume":"21","author":"Chen","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1186\/s12877-024-05379-2","article-title":"Causal linkage of Graves\u2019 disease with aging: mendelian randomization analysis of telomere length and age-related phenotypes","volume":"24","author":"Hu","year":"2024","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib4","first-page":"1","article-title":"Burden of autoimmune disorders; A review","volume":"6","author":"Morton","year":"2023","journal-title":"Asian Journal of Immunology"},{"issue":"11","key":"10.1016\/j.cpet.2026.09.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2025.100681","article-title":"Global, regional, and national burden of autoimmune disease in older adults (\u226560 years) from 1990 to 2021: results from the global Burden of Disease Study 2021","volume":"29","author":"Zeng","year":"2025","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.cpet.2026.09.002_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.semnuclmed.2007.01.001","article-title":"Increased 18F-Fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography\/computed tomography (PET\/CT): accumulated data from four years of experience with PET\/CT","volume":"37","author":"Metser","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.cpet.2026.09.002_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cpet.2026.09.002_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejrad.2010.01.021","article-title":"Role of FDG-PET and PET\/CT in the diagnosis and management of vasculitis","volume":"73","author":"Zerizer","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cpet.2026.09.002_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2018.10.003","article-title":"Introduction, epidemiology and classification of vasculitis","volume":"32","author":"Watts","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.cpet.2026.09.002_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.40520","article-title":"Review: what is the current evidence for disease subsets in giant cell arteritis?","volume":"70","author":"van der Geest","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cpet.2026.09.002_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000100","article-title":"Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review","volume":"1","author":"Mackie","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.cpet.2026.09.002_bib12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/ard-2022-222873","article-title":"Expression of interleukin-6 in synovial tissue of patients with polymyalgia rheumatica","volume":"82","author":"Jiemy","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpet.2026.09.002_bib13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis","volume":"180","author":"van der Geest","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cpet.2026.09.002_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrrheum.2017.98","article-title":"Visual loss and other cranial ischaemic complications in giant cell arteritis","volume":"13","author":"Soriano","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cpet.2026.09.002_bib15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpet.2026.09.002_bib16","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.lpm.2016.11.032","article-title":"Classification of large vessel vasculitis: can we separate giant cell arteritis from Takayasu arteritis?","volume":"46","author":"Koster","year":"2017","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.09.002_bib17","article-title":"Advanced molecular imaging in large-vessel vasculitis: adopting FDG-PET into a clinical workflow","volume":"37","author":"Ahlman","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.cpet.2026.09.002_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/687608","article-title":"The role of 18F-FDG PET\/CT in large-vessel vasculitis: appropriateness of current classification criteria?","volume":"2014","author":"Balink","year":"2014","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.cpet.2026.09.002_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/hemato4040026","article-title":"The role of PET in the diagnosis and disease activity assessment in large vessel vasculitis","volume":"4","author":"Marvisi","year":"2023","journal-title":"Hemato"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf557","article-title":"Vascular uptake on 18F-FDG PET\/CT predicts relapse in new-onset PMR","volume":"65","author":"Dai","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.cpet.2026.09.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.cpet.2026.09.002_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/ceo.13897","article-title":"Diagnosis and management of giant cell arteritis: major review","volume":"49","author":"Simon","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.cpet.2026.09.002_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.122.265016","article-title":"Role of 18F-FDG PET\/CT in large vessel vasculitis and polymyalgia rheumatica","volume":"64","author":"Slart","year":"2023","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11926-025-01204-w","article-title":"The role of FDG-PET in the diagnosis and monitoring of large-vessel vasculitis","volume":"27","author":"Tomelleri","year":"2025","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/rg.2020190047","article-title":"Fluorodeoxyglucose PET\/CT of arthritis in rheumatic diseases: a pictorial review","volume":"40","author":"Hotta","year":"2020","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.cpet.2026.09.002_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.semnuclmed.2017.02.005","article-title":"Clinical value of FDG-PET\/CT for the evaluation of rheumatic diseases: Rheumatoid arthritis, polymyalgia rheumatica, and relapsing polychondritis","volume":"47","author":"Kubota","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2967\/jnumed.110.076711","article-title":"18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study","volume":"52","author":"Elzinga","year":"2011","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2026.09.002_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4329\/wjr.v4.i12.462","article-title":"Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies","volume":"4","author":"Vijayant","year":"2012","journal-title":"World J Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib29","first-page":"69","article-title":"Spondyloarthropathies: new directions in etiopathogenesis, diagnosis and treatment","volume":"109","author":"Wilson","year":"2012","journal-title":"Mo Med"},{"issue":"6","key":"10.1016\/j.cpet.2026.09.002_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12149-016-1080-0","article-title":"18F-fluoride PET\/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity","volume":"30","author":"Idolazzi","year":"2016","journal-title":"Ann Nucl Med"},{"issue":"suppl 9","key":"10.1016\/j.cpet.2026.09.002_bib31","article-title":"Total-body 18F-FDG PET\/CT imaging: a tool for diagnosis and quantifying inflammatory burden of psoriatic arthritis","volume":"73","author":"Raychaudhuri","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-60669-4","article-title":"18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis","volume":"14","author":"Rodr\u00edguez-Fonseca","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.cpet.2026.09.002_bib33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1136\/ard.2005.040345","article-title":"FDG-PET\/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short-term evolution during anti-tumour necrosis factor treatment","volume":"64","author":"Wendling","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.cpet.2026.09.002_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/RLU.0b013e318203bb97","article-title":"F-18 FDG PET\/CT provides the earliest findings of enthesitis in reactive arthritis","volume":"36","author":"Taniguchi","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.cpet.2026.09.002_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06076.x","article-title":"PET\/CT imaging in systemic lupus erythematosus","volume":"1228","author":"Curiel","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.cpet.2026.09.002_bib36","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.cpet.2026.09.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152107","article-title":"Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: a systematic literature review","volume":"57","author":"Bentick","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cpet.2026.09.002_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/sclerosis3030031","article-title":"The use of 18F-FDG-PET in systemic sclerosis with myocardial involvement: the scleroderma heart study","volume":"3","author":"Ho","year":"2025","journal-title":"Sclerosis"},{"issue":"7","key":"10.1016\/j.cpet.2026.09.002_bib39","first-page":"1135","article-title":"[18F]FDG PET\/CT Predicts Pptient Supvival is Patients wpth Systemic Sslerosis-sclerosis-aInterstitiil Lung Diseale","volume":"66","author":"Lilburn","year":"2025","journal-title":"JdNucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2026.09.002_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","article-title":"Primary Sj\u00f6gren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients","volume":"81","author":"Garcia-Carrasco","year":"2002","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib41","first-page":"102","article-title":"Utility of FDG PET\/CT in Sj\u00f6gren's Syndrome and associated lymphomas; Lymphomagenesis","volume":"13","author":"Khan","year":"2025","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"3","key":"10.1016\/j.cpet.2026.09.002_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"issue":"1124","key":"10.1016\/j.cpet.2026.09.002_bib43","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210105","article-title":"18F-FDG PET\/CT manifestations of IgG4-related disease","volume":"94","author":"Tang","year":"2021","journal-title":"Br J Radiol"},{"issue":"8","key":"10.1016\/j.cpet.2026.09.002_bib44","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","article-title":"Characterizing IgG4-related disease with 18F-FDG PET\/CT: a prospective cohort study","volume":"41","author":"Zhang","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib45","first-page":"119","article-title":"Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases","volume":"34","author":"Zhao","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New Guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.cpet.2026.09.002_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.cpet.2026.09.002_bib49","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s10067-020-05041-3","article-title":"FDG PET\/CT used in identifying adult-onset Still\u2019s disease in connective tissue diseases","volume":"39","author":"Zhou","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cpet.2026.09.002_bib50","series-title":"Harrison\u2019s principles of internal medicine","first-page":"114","article-title":"Fever of unknown origin","author":"Bleeker-Rovers","year":"2018"},{"issue":"11","key":"10.1016\/j.cpet.2026.09.002_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.mpmed.2021.08.003","article-title":"Pyrexia of unknown origin","volume":"49","author":"Mulders-Manders","year":"2021","journal-title":"Medicine"},{"issue":"8053","key":"10.1016\/j.cpet.2026.09.002_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41586-024-08441-6","article-title":"CD45-PET is a robust, non-invasive tool for imaging inflammation","volume":"639","author":"Salehi","year":"2025","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.cpet.2026.09.002_bib53","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1073\/pnas.1524212113","article-title":"[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity","volume":"113","author":"Kim","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.cpet.2026.09.002_bib54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2967\/jnumed.119.229351","article-title":"18F-FAC PET visualizes brain-infiltrating leukocytes in a mouse model of multiple sclerosis","volume":"61","author":"Chen","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.09.002_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.902155","article-title":"Novel PET imaging of inflammatory targets and cells for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica","volume":"9","author":"van der Geest","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbrc.2018.10.083","article-title":"In vivo imaging of activated macrophages by 18F-FEDAC, a TSPO targeting PET ligand, in the use of biologic disease-modifying anti-rheumatic drugs (bDMARDs)","volume":"506","author":"Chung","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.cpet.2026.09.002_bib57","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-025-67907-x","article-title":"A radiolabeled dendrimer non-invasively identifies and tracks innate immune cell activation in a mouse model of experimental autoimmune encephalomyelitis","volume":"17","author":"James","year":"2026","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.cpet.2026.09.002_bib58","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","article-title":"68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study","volume":"3","author":"Bergmann","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"10.1016\/j.cpet.2026.09.002_bib59","doi-asserted-by":"crossref","first-page":"keag440","DOI":"10.1093\/rheumatology\/keag440","article-title":"68Ga-FAPI PET\/CT for assessing fibroblast activation and disease activity in primary Sj\u00f6gren\u2019s disease: a prospective case-control study","volume":"65","author":"Wang","year":"2026","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.cpet.2026.09.002_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2967\/jnumed.119.234484","article-title":"Imaging inflammation in atherosclerosis with CXCR4-directed 68Ga-Pentixafor PET\/CT: correlation with 18F-FDG PET\/CT","volume":"61","author":"Kircher","year":"2020","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2026.09.002_bib61","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/life12071039","article-title":"Imaging inflammation in atherosclerosis with CXCR4-directed [68Ga]PentixaFor PET\/MRI\u2014compared with [18F]FDG PET\/MRI","volume":"12","author":"Lu","year":"2022","journal-title":"Life"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:15Z","timestamp":1792096935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"alternative-id":["S1556859826001112"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.09.002","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-Fluorodeoxyglucose PET in Rheumatologic and Autoimmune Disorders","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}